John K. Cini serves as Executive at Sonnet BioTherapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, John K. Cini has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 2, 2025 involved selling 14,116 shares valued at $0.
John K. Cini currently holds 14,116 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John K. Cini has been a net neutral trader of SONN stock. They have purchased $0 and sold $0 worth of shares.
John K. Cini's most recent insider trade was on Dec 2, 2025, when they sold 14,116 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 7, 2023 | SONN | $0 | Award | 18,551 | $N/A | Discretionary |
| Jan 7, 2023 | SONN | $0 | Disposition | 18,551 | $N/A | Discretionary |
| Dec 14, 2022 | SONN | $0 | Award | 18,551 | $N/A | Discretionary |
| Dec 15, 2021 | SONN | $0 | Award | 80,034 | $N/A | Discretionary |
| May 25, 2021 | SONN | $21.1K | Payment | 14,004 | $1.51 | Discretionary |
| Jul 2, 2020 | SONN | $0 | Award | 78,214 | $N/A | Discretionary |
| Apr 1, 2020 | SONN | $0 | Award | 159,857 | $N/A | Discretionary |